THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

MARTINGALE ASSET MANAGEMENT L P's Holding History (CIK: 0000936944)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 66,458 Value ($000) $1,243 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 70,966 Value ($000) $1,036 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 68,841 Value ($000) $759 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 61,330 Value ($000) $548 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 58,650 Value ($000) $552 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 54,450 Value ($000) $439 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 47,580 Value ($000) $403 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 47,564 Value ($000) $427 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 48,664 Value ($000) $547 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 78,684 Value ($000) $679 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 78,684 Value ($000) $814 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 76,783 Value ($000) $833 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 60,742 Value ($000) $682 Avg Close $10.51 Range $9.56 - $11.83
Q3 2020
Shares 11,200 Value ($000) $166 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 9,800 Value ($000) $206 Avg Close $25.69 Range $20.17 - $31.35